English | 繁體

Search in the results

UM

Browse/Search Results:  1-2 of 2 Help

Selected(0)Clear Items/Page:    Sort:
Canagliflozin mediates mitophagy through the AMPK/PINK1/PARKIN pathway to alleviate isoprenaline-induced cardiac remodelling Journal article
Gong, Shaolin, Sui, Yuan, Xiao, Mengxuan, Fu, Daoyao, Xiong, Zhiping, Zhang, Liuping, Tian, Qingshan, Fu, Yongnan, Xiong, Wenjun. Canagliflozin mediates mitophagy through the AMPK/PINK1/PARKIN pathway to alleviate isoprenaline-induced cardiac remodelling[J]. Journal of Cardiovascular Pharmacology, 2024, 84(5), 496-505.
Authors:  Gong, Shaolin;  Sui, Yuan;  Xiao, Mengxuan;  Fu, Daoyao;  Xiong, Zhiping; et al.
Favorite | TC[WOS]:1 TC[Scopus]:0  IF:2.6/2.5 | Submit date：2024/09/03
Canagliflozin  Cardiac Remodeling  Cardioprotective  Mitophagy  Sglt-2 Inhibitor  
Recent discoveries of the role of histone modifications and related inhibitors in pathological cardiac hypertrophy Journal article
Wu, Ke Jia, Chen, Qi, Leung, Chung Hang, Sun, Ning, Gao, Fei, Chen, Zhaoyang. Recent discoveries of the role of histone modifications and related inhibitors in pathological cardiac hypertrophy[J]. Drug Discovery Today, 2024, 29(2), 103878.
Authors:  Wu, Ke Jia;  Chen, Qi;  Leung, Chung Hang;  Sun, Ning;  Gao, Fei; et al.
Favorite | TC[WOS]:2 TC[Scopus]:2  IF:6.5/7.3 | Submit date：2024/02/22
Chromatin Remodeling  Epigenetics  Heart Failure  Histone Modification  Pathological Cardiac Hypertrophy